Investigating the link between miR-34a-5p and TLR6 signaling in sepsis-induced ARDS
暂无分享,去创建一个
Ganesh Bagler | A. Nayek | M. Chopra | Shakir Ali | Prithvi Singh | M. Malik | Kalaiarasan Ponnusamy | M. Syed | Ravins Dohare | P. Jha | I. Singh | Mohd Junaid Khan | Bhupender Kumar | Bhupender Kumar | Madhu Chopra
[1] D. Saluja,et al. Structure-guided pharmacophore based virtual screening, docking, and molecular dynamics to discover repurposed drugs as novel inhibitors against endoribonuclease Nsp15 of SARS-CoV-2 , 2022, Journal of biomolecular structure & dynamics.
[2] A. Nayek,et al. Integrative multiomics and in silico analysis revealed the role of ARHGEF1 and its screened antagonist in mild and severe COVID‐19 patients , 2022, Journal of cellular biochemistry.
[3] S. Mohammed,et al. Serum miR-34a-5p and miR-199a-3p as new biomarkers of neonatal sepsis , 2022, PloS one.
[4] M. Taheri,et al. Regulatory Role of Non-Coding RNAs on Immune Responses During Sepsis , 2021, Frontiers in Immunology.
[5] F. Perez-Vizcaino,et al. Serum MicroRNAs as Biomarkers of Sepsis and Resuscitation , 2021, Applied Sciences.
[6] I. Douglas,et al. Metabolic Syndrome and Acute Respiratory Distress Syndrome in Hospitalized Patients With COVID-19 , 2021, JAMA network open.
[7] Linlin Zhang,et al. The Association Between Etiologies and Mortality in Acute Respiratory Distress Syndrome: A Multicenter Observational Cohort Study , 2021, Frontiers in Medicine.
[8] Z. Hu,et al. Comparative Study of Acute Lung Injury in COVID-19 and Non-COVID-19 Patients , 2021, Frontiers in Medicine.
[9] Lihua Wang,et al. Construction of a TF–miRNA–gene feed-forward loop network predicts biomarkers and potential drugs for myasthenia gravis , 2021, Scientific Reports.
[10] H. Bai,et al. STAT6 up-regulation amplifies M2 macrophage anti-inflammatory capacity through mesenchymal stem cells. , 2020, International immunopharmacology.
[11] Ling Fang,et al. TRPM7 modulates macrophage polarization by STAT1/STAT6 pathways in RAW264.7 cells. , 2020, Biochemical and biophysical research communications.
[12] H-J Wang,et al. MiR-34a-5p inhibition attenuates LPS-induced endothelial cell injury by targeting FOXM1. , 2020, European review for medical and pharmacological sciences.
[13] M. Zeitlinger,et al. Incidence of ARDS and outcomes in hospitalized patients with COVID-19: a global literature survey , 2020, Critical Care.
[14] Shakir Ali,et al. Inhibition of miRNA-34a Promotes M2 Macrophage Polarization and Improves LPS-Induced Lung Injury by Targeting Klf4 , 2020, Genes.
[15] Shijiao Yan,et al. MicroRNA-34a Inhibition Alleviates Lung Injury in Cecal Ligation and Puncture Induced Septic Mice , 2020, Frontiers in Immunology.
[16] J. Shen,et al. MicroRNA: Potential biomarker and target of therapy in acute lung injury , 2020, Human & experimental toxicology.
[17] Cuiping Hao,et al. From sepsis to acute respiratory distress syndrome (ARDS): emerging preventive strategies based on molecular and genetic researches , 2020, Bioscience reports.
[18] A. Ramírez-Venegas,et al. miR-34a in serum is involved in mild-to-moderate COPD in women exposed to biomass smoke , 2019, BMC Pulmonary Medicine.
[19] Ping Wang,et al. DAMPs and NETs in Sepsis , 2019, Front. Immunol..
[20] Jun Chen,et al. STAT6/Arg1 promotes microglia/macrophage efferocytosis and inflammation resolution in stroke mice. , 2019, JCI insight.
[21] J. Qin,et al. Modulation of M2 macrophage polarization by the crosstalk between Stat6 and Trim24 , 2019, Nature Communications.
[22] A. Malik,et al. STAT6 induces expression of Gas6 in macrophages to clear apoptotic neutrophils and resolve inflammation , 2019, Proceedings of the National Academy of Sciences.
[23] Z. Fejes,et al. Role of sepsis modulated circulating microRNAs , 2019, EJIFCC.
[24] Kathleen M. Jagodnik,et al. ChEA3: transcription factor enrichment analysis by orthogonal omics integration , 2019, Nucleic Acids Res..
[25] M. Locati,et al. MicroRNAs as Molecular Switches in Macrophage Activation , 2019, Front. Immunol..
[26] Y. Wang,et al. MicroRNA-494-3p alleviates inflammatory response in sepsis by targeting TLR6. , 2019, European review for medical and pharmacological sciences.
[27] B. Gyawali,et al. Sepsis: The evolution in definition, pathophysiology, and management , 2019, SAGE open medicine.
[28] J. Englert,et al. Integrating molecular pathogenesis and clinical translation in sepsis-induced acute respiratory distress syndrome. , 2019, JCI insight.
[29] V. Mata-Haro,et al. Regulation of TLR signaling pathways by microRNAs: implications in inflammatory diseases , 2018, Central-European journal of immunology.
[30] P. Devillier,et al. The Role of Toll-Like Receptors in the Production of Cytokines by Human Lung Macrophages , 2018, Journal of Innate Immunity.
[31] Carsten Sticht,et al. miRWalk: An online resource for prediction of microRNA binding sites , 2018, PloS one.
[32] C. Shi,et al. MicroRNA-34a promotes iNOS secretion from pulmonary macrophages in septic suckling rats through activating STAT3 pathway. , 2018, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[33] Xuetao Cao,et al. Src promotes anti‐inflammatory (M2) macrophage generation via the IL‐4/STAT6 pathway , 2018, Cytokine.
[34] C. Peng,et al. Overview of MicroRNA Biogenesis, Mechanisms of Actions, and Circulation , 2018, Front. Endocrinol..
[35] Jong Seong Roh,et al. Damage-Associated Molecular Patterns in Inflammatory Diseases , 2018, Immune network.
[36] K. Dhaliwal,et al. Cerebral Concussion Primes the Lungs for Subsequent Neutrophil-Mediated Injury , 2018, Critical care medicine.
[37] Ping Chen,et al. miR-34a is involved in CSE-induced apoptosis of human pulmonary microvascular endothelial cells by targeting Notch-1 receptor protein , 2018, Respiratory Research.
[38] N. Ambalavanan,et al. Hyperoxia causes miR-34a-mediated injury via angiopoietin-1 in neonatal lungs , 2017, Nature Communications.
[39] J. Rello,et al. Sepsis: A Review of Advances in Management , 2017, Advances in Therapy.
[40] A. Ma,et al. STAT6 Upregulation Promotes M2 Macrophage Polarization to Suppress Atherosclerosis , 2017, Medical science monitor basic research.
[41] J. Lorente,et al. Acute Respiratory Distress Syndrome and Diffuse Alveolar Damage. New Insights on a Complex Relationship. , 2017, Annals of the American Thoracic Society.
[42] S. Shetty,et al. p53 and miR-34a Feedback Promotes Lung Epithelial Injury and Pulmonary Fibrosis. , 2017, The American journal of pathology.
[43] G. Rubenfeld,et al. Fifty Years of Research in ARDS., The Epidemiology of Acute Respiratory Distress Syndrome. A 50th Birthday Review , 2017, American journal of respiratory and critical care medicine.
[44] Amir K. Foroushani,et al. Large-scale gene network analysis reveals the significance of extracellular matrix pathway and homeobox genes in acute myeloid leukemia: an introduction to the Pigengene package and its applications , 2017, BMC Medical Genomics.
[45] K. Kuwano,et al. Amphiregulin suppresses epithelial cell apoptosis in lipopolysaccharide-induced lung injury in mice. , 2017, Biochemical and biophysical research communications.
[46] Gang Liu,et al. miR-34a promotes fibrosis in aged lungs by inducing alveolarepithelial dysfunctions. , 2017, American journal of physiology. Lung cellular and molecular physiology.
[47] Abderrahim Chafik. miR-34a-5p and miR-34a-3p contribute to the signaling pathway of p53 by targeting overlapping sets of genes , 2016, 1608.02756.
[48] R. Hotchkiss,et al. Sepsis and septic shock , 2016, Nature Reviews Disease Primers.
[49] Jihong Yao,et al. miR-34a-5p Inhibition Alleviates Intestinal Ischemia/Reperfusion-Induced Reactive Oxygen Species Accumulation and Apoptosis via Activation of SIRT1 Signaling. , 2016, Antioxidants & redox signaling.
[50] Yongmei Cao,et al. MicroRNAs: Novel regulatory molecules in acute lung injury/acute respiratory distress syndrome. , 2016, Biomedical reports.
[51] M. Balaan,et al. Acute Respiratory Distress Syndrome , 2016, Critical care nursing quarterly.
[52] Sang-Bum Hong,et al. Sepsis and Acute Respiratory Distress Syndrome: Recent Update , 2016, Tuberculosis and respiratory diseases.
[53] Anders Larsson,et al. Epidemiology, Patterns of Care, and Mortality for Patients With Acute Respiratory Distress Syndrome in Intensive Care Units in 50 Countries. , 2016, JAMA.
[54] J. Eiserich,et al. Lung Neutrophilia in Myeloperoxidase Deficient Mice during the Course of Acute Pulmonary Inflammation , 2016, Oxidative medicine and cellular longevity.
[55] B. Wolf,et al. Plasma levels of microRNA are altered with the development of shock in human sepsis: an observational study , 2015, Critical Care.
[56] Bo Yu,et al. Roles of microRNA-34a targeting SIRT1 in mesenchymal stem cells , 2015, Stem Cell Research & Therapy.
[57] J. Lieberman,et al. miR-34 and p53: New Insights into a Complex Functional Relationship , 2015, PloS one.
[58] Matthew E. Ritchie,et al. limma powers differential expression analyses for RNA-sequencing and microarray studies , 2015, Nucleic acids research.
[59] Y. Luan,et al. Insights into the apoptotic death of immune cells in sepsis. , 2015, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.
[60] A. Lackner,et al. Dysregulated miR-34a–SIRT1–Acetyl p65 Axis Is a Potential Mediator of Immune Activation in the Colon during Chronic Simian Immunodeficiency Virus Infection of Rhesus Macaques , 2015, The Journal of Immunology.
[61] L. Schaefer. Complexity of Danger: The Diverse Nature of Damage-associated Molecular Patterns* , 2014, The Journal of Biological Chemistry.
[62] T. Jang,et al. Crystal structure of TIR domain of TLR6 reveals novel dimeric interface of TIR-TIR interaction for toll-like receptor signaling pathway. , 2014, Journal of molecular biology.
[63] Taro Kawai,et al. Toll-Like Receptor Signaling Pathways , 2014, Front. Immunol..
[64] T. Jang,et al. Crystal structure of TIR domain of TLR6 , 2014 .
[65] Rajendra Kumar,et al. g_mmpbsa - A GROMACS Tool for High-Throughput MM-PBSA Calculations , 2014, J. Chem. Inf. Model..
[66] D. Harn,et al. Mir-34a regulates macrophage polarization by targeting IL-4Ralpa/STAT6 axis (INM2P.423) , 2014, The Journal of Immunology.
[67] S. Bellamy,et al. The Epidemiology of Acute Respiratory Distress Syndrome in Patients Presenting to the Emergency Department With Severe Sepsis , 2013, Shock.
[68] Derin Tugal,et al. Transcriptional control of macrophage polarization. , 2013, Arteriosclerosis, thrombosis, and vascular biology.
[69] G. Sigurdsson,et al. Acute respiratory distress syndrome: nationwide changes in incidence, treatment and mortality over 23 years , 2013, Acta anaesthesiologica Scandinavica.
[70] Zhongming Zhao,et al. Uncovering MicroRNA and Transcription Factor Mediated Regulatory Networks in Glioblastoma , 2012, PLoS Comput. Biol..
[71] P. Massari,et al. The Role of TLR2 in Infection and Immunity , 2012, Front. Immun..
[72] V. Dixit,et al. Signaling in innate immunity and inflammation. , 2012, Cold Spring Harbor perspectives in biology.
[73] Hanmin Wang,et al. Hypoxia-Induced Down-Regulation of microRNA-34a Promotes EMT by Targeting the Notch Signaling Pathway in Tubular Epithelial Cells , 2012, PloS one.
[74] W. Robinson,et al. Plasma proteins present in osteoarthritic synovial fluid can stimulate cytokine production via Toll-like receptor 4 , 2012, Arthritis Research & Therapy.
[75] Xueyuan Bai,et al. miR-335 and miR-34a Promote renal senescence by suppressing mitochondrial antioxidative enzymes. , 2011, Journal of the American Society of Nephrology : JASN.
[76] K. Raghavendran,et al. Definition of ALI/ARDS. , 2011, Critical care clinics.
[77] O. Soehnlein,et al. Contribution of Neutrophils to Acute Lung Injury , 2011, Molecular medicine.
[78] E. Izaurralde,et al. Gene silencing by microRNAs: contributions of translational repression and mRNA decay , 2011, Nature Reviews Genetics.
[79] V. Kim,et al. Regulation of microRNA biogenesis , 2014, Nature Reviews Molecular Cell Biology.
[80] D. Bartel. MicroRNAs: Target Recognition and Regulatory Functions , 2009, Cell.
[81] J. Lang,et al. Lymphocytes, apoptosis and sepsis: making the jump from mice to humans , 2009, Critical care.
[82] S. Horvath,et al. WGCNA: an R package for weighted correlation network analysis , 2008, BMC Bioinformatics.
[83] M. Yamakuchi,et al. miR-34a repression of SIRT1 regulates apoptosis , 2008, Proceedings of the National Academy of Sciences.
[84] X. Zhang,et al. Macrophage activation by endogenous danger signals , 2008, The Journal of pathology.
[85] W. Cioffi,et al. Fas-induced pulmonary apoptosis and inflammation during indirect acute lung injury. , 2007, American journal of respiratory and critical care medicine.
[86] Michael A. Beer,et al. Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis. , 2007, Molecular cell.
[87] Mark E. J. Newman,et al. Power-Law Distributions in Empirical Data , 2007, SIAM Rev..
[88] B. Billack. Macrophage activation: role of toll-like receptors, nitric oxide, and nuclear factor kappa B. , 2006, American journal of pharmaceutical education.
[89] S. Horvath,et al. Statistical Applications in Genetics and Molecular Biology , 2011 .
[90] L. Joosten,et al. Expression of toll-like receptors 2 and 4 in rheumatoid synovial tissue and regulation by proinflammatory cytokines interleukin-12 and interleukin-18 via interferon-gamma. , 2004, Arthritis and rheumatism.
[91] A. Isibasi,et al. Toll-like receptors: dysregulation in vivo in patients with acute respiratory distress syndrome. , 2004, Revista alergia Mexico.
[92] Shizuo Akira,et al. TLR signaling pathways. , 2004, Seminars in immunology.
[93] R. Hotchkiss,et al. Role of Apoptotic Cell Death in Sepsis , 2003, Scandinavian journal of infectious diseases.
[94] Andrew D Bersten,et al. Incidence and mortality of acute lung injury and the acute respiratory distress syndrome in three Australian States. , 2002, American journal of respiratory and critical care medicine.
[95] G. Downey,et al. Neutrophil-mediated epithelial injury during transmigration: role of elastase. , 2001, American journal of physiology. Gastrointestinal and liver physiology.
[96] K. Kooguchi,et al. Fas/FasL-dependent apoptosis of alveolar cells after lipopolysaccharide-induced lung injury in mice. , 2001, American journal of respiratory and critical care medicine.
[97] K. Kuwano,et al. Upregulation of Fas-signalling molecules in lung epithelial cells from patients with idiopathic pulmonary fibrosis. , 2001, The European respiratory journal.
[98] K. Kuwano,et al. Protection from lethal apoptosis in lipopolysaccharide-induced acute lung injury in mice by a caspase inhibitor. , 2000, The American journal of pathology.
[99] R. Hotchkiss,et al. Apoptotic cell death in patients with sepsis, shock, and multiple organ dysfunction. , 1999, Critical care medicine.
[100] M. Fleming,et al. Association of p53 and WAF1 expression with apoptosis in diffuse alveolar damage. , 1996, The American journal of pathology.
[101] Ting Yu,et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study , 2020, The Lancet Respiratory Medicine.
[102] A. Ferruelo,et al. MicroRNAs as biomarkers of acute lung injury. , 2018, Annals of translational medicine.
[103] Tanya Barrett,et al. The Gene Expression Omnibus Database , 2016, Statistical Genomics.
[104] L. Moldawer,et al. DAMPs, PAMPs, and the origins of SIRS in bacterial sepsis. , 2013, Shock.
[105] N. Matsuda,et al. Insights into sepsis therapeutic design based on the apoptotic death pathway. , 2010, Journal of pharmacological sciences.
[106] G. Criner,et al. Acute Lung Injury (ALI) and Acute Respiratory Distress Syndrome (ARDS) , 2010 .
[107] G. Matute-Bello,et al. Lymphocytes, apoptosis and sepsis , 2009 .
[108] E. Pressman,et al. DEPARTMENT OF , 2009 .
[109] L. Eckmann. CHAPTER 42 – Innate Immunity , 2006 .
[110] N. Hagimoto,et al. Apoptosis and epithelial injury in the lungs. , 2005, Proceedings of the American Thoracic Society.
[111] A. Ellrodt,et al. Sepsis and septic shock. , 1986, Emergency medicine clinics of North America.